Baudax Bio, Inc. (BXRXQ)
0.0000
0.00 (0.00%)
USD |
OTCM |
Aug 28, 16:00
Baudax Bio Cash from Financing (Quarterly)
Cash from Financing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Financing (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2023 | 1.475M |
| June 30, 2023 | 1.114M |
| March 31, 2023 | 3.208M |
| December 31, 2022 | 3.395M |
| September 30, 2022 | 3.325M |
| June 30, 2022 | 1.402M |
| March 31, 2022 | 9.059M |
| December 31, 2021 | 3.742M |
| September 30, 2021 | -0.078M |
| June 30, 2021 | 9.428M |
| March 31, 2021 | 21.92M |
| December 31, 2020 | 20.70M |
| Date | Value |
|---|---|
| September 30, 2020 | -2.69M |
| June 30, 2020 | 12.43M |
| March 31, 2020 | 26.86M |
| December 31, 2019 | 25.37M |
| September 30, 2019 | 3.027M |
| June 30, 2019 | 26.05M |
| March 31, 2019 | 14.82M |
| December 31, 2018 | 14.16M |
| September 30, 2018 | 15.92M |
| June 30, 2018 | 14.51M |
| March 31, 2018 | 18.61M |
Cash From Financing Definition
Represents the net cash flow resulting from the company's financing activities. Financing activities represent movement in the company's debt and share capital and other activities.
Cash from Financing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Financing (Quarterly) Benchmarks
| ANI Pharmaceuticals, Inc. | -4.647M |
| Corcept Therapeutics, Inc. | -2.037M |
| Veru, Inc. | -0.0519M |
| Johnson & Johnson | -8.777B |
| Eli Lilly & Co. | 8.426B |